Antibacterial immunity of lower airways: local or localized?
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
3891551
DOI
10.1007/bf02923517
Knihovny.cz E-zdroje
- MeSH
- bronchy imunologie MeSH
- časové faktory MeSH
- fagocyty imunologie MeSH
- imunizace MeSH
- imunoglobulin A imunologie MeSH
- infekce bakteriemi rodu Klebsiella imunologie MeSH
- Klebsiella pneumoniae MeSH
- myši MeSH
- plicní alveoly imunologie MeSH
- plicní nemoci imunologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- imunoglobulin A MeSH
Clearance of bacteria in the bronchoalveolar lavage, the level and functional activity of IgA and changes in the cellular composition of BAL were examined in mice after supralaryngeal immunization and subsequent challenge with Klebsiella pneumoniae. More than 60% of the bacterial inoculum was removed by nonspecific mechanisms within 90 min after inoculation; within the time interval 1.5-3.5 h, clearance was significantly accelerated in locally immunized mice. The enhancement of clearance effectiveness is specific and increases proportionally with the length of immunization (1 less than 2 less than 4 weeks); it is of short duration and towards the end of the 3rd week after immunization, in 73% of immunized animals, the clearance values did not differ from values found in controls. The local immunization did not influence the total level of IgA in BAL, the formation of specific IgA antibody was minimal, in vivo binding of IgA to klebsiella could not be demonstrated. In immunized mice, a significant increase in the numbers of PMN and lymphocytes, as well as an increased activity of phagocytic cell (PMN, MP) was found in BAL. The time interval of 1.5-3.5 h after challenge bounds the space for mechanisms, activated by local immunization in lower airways. The actual participation of individual factors in the accelerated elimination of bacteria from the lumen of airways, remains unclear so far.
Zobrazit více v PubMed
Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S637-46 PubMed
J Clin Invest. 1975 Aug;56(2):376-85 PubMed
Folia Microbiol (Praha). 1983;28(5):430-4 PubMed
Bull Eur Physiopathol Respir. 1983 Mar-Apr;19(2):215-26 PubMed
Am Rev Respir Dis. 1977 Aug;116(2):241-9 PubMed
Infect Immun. 1978 Jul;21(1):185-93 PubMed
Infect Immun. 1984 Jan;43(1):440-1 PubMed
J Infect Dis. 1983 Feb;147(2):312-7 PubMed
Bull Eur Physiopathol Respir. 1983 Mar-Apr;19(2):151-61 PubMed
Folia Biol (Praha). 1983;29(6):424-8 PubMed
J Clin Invest. 1980 Aug;66(2):194-9 PubMed
Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S852-7 PubMed
J Infect Dis. 1980 Sep;142(3):421-31 PubMed
Bull Eur Physiopathol Respir. 1977 Jan-Feb;13(1):57-67 PubMed
Br J Exp Pathol. 1979 Oct;60(5):471-82 PubMed
Folia Microbiol (Praha). 1983;28(5):424-9 PubMed
Folia Microbiol (Praha). 1984;29(5):375-84 PubMed
Gastroenterology. 1983 Jan;84(1):178-85 PubMed
Am Rev Respir Dis. 1976 Mar;113(3):347-79 PubMed
Am Rev Respir Dis. 1977 Oct;116(4):679-84 PubMed
Clin Exp Immunol. 1984 May;56(2):302-10 PubMed
Am Rev Respir Dis. 1977 Jan;115(1):89-95 PubMed